Premium
Low COX2 in tumor and upregulation in stroma mark laryngeal squamous cell carcinoma progression
Author(s) -
Kourelis Konstantinos,
Vandoros Gerasimos,
Kourelis Theodoros,
Papadas Theodoros,
Goumas Panos,
SotiropoulouBonikou Georgia
Publication year - 2009
Publication title -
the laryngoscope
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.181
H-Index - 148
eISSN - 1531-4995
pISSN - 0023-852X
DOI - 10.1002/lary.20569
Subject(s) - stromal cell , immunostaining , medicine , cancer , immunohistochemistry , tumor progression , stroma , pathology , head and neck squamous cell carcinoma , tumor microenvironment , cancer associated fibroblasts , larynx , cancer cell , cancer research , head and neck cancer , surgery
Objectives/Hypothesis: Invasive squamous cell carcinomas (SCC) of the larynx, like most solid tumors, are surrounded by a reactive stroma, in which cancer associated fibroblasts (CAFs) are the predominant cell type. This mesenchymal reaction may affect cancer progression multiply. The proinflammatory enzyme cyclooxygenase‐2 (COX‐2) has been correlated with head and neck cancer. This study aims to explore the impact of epithelial and stromal COX‐2 expression on SCC behavior. Study Design: Retrospective case review study performed in a tertiary health center institution. Methods: Double immunohistochemistry of COX‐2 and the CAF marker α‐smooth muscle actin (α‐SMA) was utilized in 97 laryngeal cancer patients. Follow‐up data were collected in 52 cases. Results: Low COX‐2 immunostaining in cancer cells was associated with advanced grade ( P = .044) and shorter recurrence‐free period ( P = .035). CAF expression was positively correlated with the grade of the infiltrating tumor ( P = .030). Conclusions: In laryngeal SCCs, COX‐2 may exert its deleterious effect by alterations in the tumor microenvironment. CAF‐derived, COX‐2‐mediated paracrine influences on malignant cells possibly facilitate cancer progression. Overlooking the stromal remodeling could account for unsuccessful treatments of epithelial neoplasms. Laryngoscope, 2009